HomeDXCM • NASDAQ
DexCom Inc
add
$84.51
0.38%
After Hours:(2.58%)-2.18
$82.33
Closed: May 23, 4:44:25 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.04B | 12.49% |
Operating expense | 455.30M | -1.19% |
Net income | 105.40M | -28.01% |
Net profit margin | 10.17 | -36.04% |
Earnings per share | 0.32 | 0.00% |
EBITDA | 193.70M | 26.11% |
Effective tax rate | 31.69% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.70B | -6.75% |
Total assets | 6.75B | 4.16% |
Total liabilities | 4.49B | 5.90% |
Total equity | 2.27B | — |
Shares outstanding | 392.11M | — |
Price to book | 14.68 | — |
Return on assets | 5.05% | — |
Return on capital | 7.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 105.40M | -28.01% |
Cash from operations | 183.80M | -12.14% |
Cash from investing | 100.20M | 33.96% |
Cash from financing | 12.50M | 165.96% |
Net change in cash | 298.80M | 4.88% |
Free cash flow | 67.93M | -39.14% |
Previous close
$84.83
Day range
$83.48 - $85.01
Year range
$57.52 - $128.63
Market cap
33.14B USD
Avg Volume
4.27M
P/E ratio
64.80
Dividend yield
-
Primary exchange
NASDAQ
About
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250